PHARMACYCLICS INC Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2014 12 months to Dec 31, 2014	FY2013 12 months to Dec 31, 2013	FY2012 6 months to Dec 31, 2012	FY2011 12 months to Jun 30, 2012
Revenue:
Product revenue, net
License and milestone revenue
Collaboration services revenue
Total revenue
Costs and expenses:
Cost of goods sold
Research and development
Less: Excess Amounts related to Research and development
Research and development, net
Selling, General and Administrative Expense, Including Excess Amounts from Collaborative Agreements
Less: Excess Amounts related to Selling, general and administrative
Selling, general and administrative
Total costs of collaboration (Janssen's 50% share under the Agreement)
Amortization of intangible assets
Total costs and expenses
Income from operations
Interest income
Other expense, net
Income before income taxes
Income tax provision
Net income
Net income per share:
Basic (in dollars per share)
Diluted (in dollars per share)
Weighted average shares used to compute net income per share:
Basic (in shares)
Diluted (in shares)

Comments